Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00899521
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
PPL![]() | PIPERIDINE-2-CARBOXYLIC ACID TERT- BUTYLAMIDE | A,B | 1IDB | 0.72 | ![]() |
PPL![]() | PIPERIDINE-2-CARBOXYLIC ACID TERT- BUTYLAMIDE | A,B | 1IDA | 0.72 | ![]() |
GIO![]() | CYCLO-(GLYCINE-L-PROLINE) INHIBITOR | A,B | 1W1P | 0.74 | ![]() |
BPR![]() | (2R)-N-[(2R)-2-(DIHYDROXYBORYL)- 1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)- 5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN- 2-YL]-L-PROLINAMIDE | A,B,C,D | 2AJD | 0.72 | ![]() |
INN![]() | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3EDZ | 0.71 | ![]() |
INN![]() | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3EWJ | 0.71 | ![]() |
INN![]() | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 2DDF | 0.71 | ![]() |
INN![]() | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B,C,D | 2I47 | 0.71 | ![]() |
INN![]() | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,C,E,I | 1BKC | 0.71 | ![]() |
INN![]() | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 2FV9 | 0.71 | ![]() |
INN![]() | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3E8R | 0.71 | ![]() |
AIO![]() | [(2R)-1-(L-ALANYL-L-ISOLEUCYL)PYRROLIDIN- 2-YL]BORONIC ACID | A | 2EEP | 0.8 | ![]() |
AIO![]() | [(2R)-1-(L-ALANYL-L-ISOLEUCYL)PYRROLIDIN- 2-YL]BORONIC ACID | A | 2Z3Z | 0.8 | ![]() |
HU1![]() | TERT-BUTYL {(1S)-2-[(1R,2S,5S)- 2-({[(1S)-3-AMINO-1-(CYCLOBUTYLMETHYL)- 2,3-DIOXOPROPYL]AMINO}CARBONYL)- 6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEX- 3-YL]-1-CYCLOHEXYL-2-OXOETHYL}CARBAMATE | A,C | 2OC0 | 0.71 | ![]() |
HU5![]() | (1R,2S,5S)-N-[(1S)-3-AMINO-1-(CYCLOBUTYLMETHYL)- 2,3-DIOXOPROPYL]-3-[(2S)-2-{[(TERT- BUTYLAMINO)CARBONYL]AMINO}-3,3- DIMETHYLBUTANOYL]-6,6-DIMETHYL- 3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE | A,C | 2OC8 | 0.71 | ![]() |
ALJ![]() | CYCLO-(L-ARGININE-L-PROLINE) INHIBITOR | A,B | 1W1V | 0.71 | ![]() |
CIB![]() | 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1- (1-FORMYL-PENTYLCARBAMOYL)-3-METHYL- BUTYL]-AMIDE | H,I,J,K,L,M,N | 1J2Q | 0.72 | ![]() |
A3M![]() | 2-AMINO-3-METHYL-1-PYRROLIDIN-1- YL-BUTAN-1-ONE | A,B | 1N1M | 0.72 | ![]() |
OHM![]() | 3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3- YL]DODECANAMIDE | B,H | 2NTF | 0.72 | ![]() |
277![]() | N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)- 3-FLUOROPYRROLIDIN-1-YL]-1-METHYL- 3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE | A,B | 2OPH | 0.75 | ![]() |
KCQ![]() | (3S)-3-[(2S)-2-AMINO-3-OXOBUTYL]PYRROLIDIN- 2-ONE | A,I | 2Z3E | 0.74 | ![]() |
HUD![]() | TERT-BUTYL [(1S)-1-{[(1R,2S,5S)- 2-({[(1S)-3-AMINO-1-(CYCLOPROPYLMETHYL)- 2,3-DIOXOPROPYL]AMINO}CARBONYL)- 6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEX- 3-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE | A,C | 2OBO | 0.7 | ![]() |